Apollomics Inc. (APLM) shareholders
Close on Nov 16, 2026Market cap $39.18MP/E –Yield –
Ownership
Who owns Apollomics's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Hung-Wen Chen Joint filing with King Regent Management Limited (35.32%) | 1,453,029 | 49.76% | 13D (active) amendment | Aug 14, 2026 |
| King Regent Management Limited Joint filing with Hung-Wen Chen (41.80%) | 901,362 | 41.80% | 13D (active) amendment | Mar 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Yi-Kuei Chen | Chief Operating Officer, Director | 141,348 | Sep 24, 2026 |
| Hung-Wen Chen | Chief Executive Officer, Director, 10% owner | 1,453,029 | Sep 17, 2026 |
| Peter Kuan-How Lin | Chief Financial Officer | 58,979 | Sep 24, 2026 |
| Hung Hsien Yen | Director | 500 | Sep 24, 2026 |
| Ya-Chi Huang | Director | 1,500 | Sep 17, 2026 |
| Hsien-Shu Tsai | Director | 2,000 | Sep 17, 2026 |
| Hong-Jung Chen | Director | 4,120 | Sep 17, 2026 |
| Yi-An Chu | Director | 1,500 | Jun 16, 2026 |
| Chen-Huan Jan | Director | 1,500 | Jun 16, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Peter Kuan-How Lin Chief Financial Officer | Sep 15, 2026 | Option exercise | +10,000 | – | – | 58,979 |
| Peter Kuan-How Lin Chief Financial Officer | Sep 15, 2026 | Tax withholding | −3,416 | $24.02 | $82.05K | 55,563 |
| Yi-Kuei Chen Chief Operating Officer, Director | Sep 15, 2026 | Option exercise | +5,000 | – | – | 20,100 |
| Hung Hsien Yen Director | Sep 15, 2026 | Option exercise | +500 | – | – | 500 |
| Yi-Kuei Chen Chief Operating Officer, Director | Sep 15, 2026 | Option exercise | +5,000 | – | – | 20,100 |
| Hong-Jung Chen Director | Sep 15, 2026 | Option exercise | +500 | – | – | 4,120 |
| Hsien-Shu Tsai Director | Sep 15, 2026 | Option exercise | +500 | – | – | 2,000 |
| Hung-Wen Chen Chief Executive Officer, Director, 10% owner | Sep 15, 2026 | Option exercise | +5,000 | – | – | 423,334 |
| Peter Kuan-How Lin Chief Financial Officer, Director | Sep 15, 2026 | Option exercise | +10,000 | – | – | 58,979 |
| Peter Kuan-How Lin Chief Financial Officer, Director | Sep 15, 2026 | Tax withholding | −3,416 | $24.02 | $82.05K | 55,563 |
| Hung Hsien Yen Director | Sep 15, 2026 | Option exercise | +500 | – | – | 500 |
| Ya-Chi Huang Director | Aug 17, 2026 | Option exercise | +500 | – | – | 1,500 |
| Peter Kuan-How Lin Chief Financial Officer | Aug 14, 2026 | Buy | +26,667 | $15.00 | $400.01K | 48,979 |
| Yi-Kuei Chen Chief Operating Officer, Director | Aug 14, 2026 | Buy | +20,000 | $15.00 | $300.00K | 121,248 |
| Hung-Wen Chen Chief Executive Officer, Director | Aug 14, 2026 | Buy | +103,333 | $15.00 | $1.55M | 418,334 |
| Hung-Wen Chen Chief Executive Officer, Director | Aug 14, 2026 | Buy | +166,667 | $12.00 | $2.00M | 315,001 |
| Hung-Wen Chen Chief Executive Officer, Director | Aug 14, 2026 | Buy | +266,667 | $15.00 | $4.00M | 1,029,695 |
| Peter Kuan-How Lin Chief Financial Officer, Director | Jun 15, 2026 | Option exercise | +10,000 | – | – | 25,900 |
| Peter Kuan-How Lin Chief Financial Officer, Director | Jun 15, 2026 | Tax withholding | −3,588 | $13.85 | $49.69K | 22,312 |
| Hsien-Shu Tsai Director | Jun 15, 2026 | Option exercise | +500 | – | – | 1,500 |
| Yi-Kuei Chen Chief Operating Officer, Director | Jun 15, 2026 | Option exercise | +5,000 | – | – | 15,000 |
| Chen-Huan Jan Director | Jun 15, 2026 | Option exercise | +500 | – | – | 1,500 |
| Hong-Jung Chen Director | Jun 15, 2026 | Option exercise | +500 | – | – | 3,620 |
| Hung-Wen Chen Chief Executive Officer, Director | Jun 15, 2026 | Option exercise | +5,000 | – | – | 148,334 |
| Yi-An Chu Director | Jun 15, 2026 | Option exercise | +500 | – | – | 1,500 |
| Ya-Chi Huang Director | May 17, 2026 | Option exercise | +500 | – | – | 1,000 |
| Peter Kuan-How Lin Chief Financial Officer | Mar 31, 2026 | Tax withholding | −3,582 | $15.85 | $56.77K | 12,318 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Apollomics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,225 shares on Aug 26, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| OrbiMed Asia Partners II, L.P. Shareholder | Nov 27, 2023 | 9,515,756 | $11.32M | Nov 27, 2023 | Business combination |
| OrbiMed Asia Partners II, L.P. Shareholder | Nov 16, 2023 | 16,183,185 | $28.64M | Nov 16, 2023 | Business combination |
| OrbiMed Asia Partners, L.P. Shareholder | Oct 30, 2023 | 915,670 | $789.31K | Oct 30, 2023 | Business combination |
| OrbiMed Asia Partners, L.P. Shareholder | Oct 5, 2023 | 894,807 | $2.86M | Oct 5, 2023 | Business combination |
See a number that looks wrong?